Replies to post #203819 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

ODD only has value if and when approval happens. By implication of your thinking, $AVXL should sky rocket in anticipation of approval.

[Steady_T]

This should skyrocket on that news

Why?

History has shown that AVXL doesn't respond well to positive news. Is there any reason for expectations to be different this time?

ODD designation is nice and until 2-73 has shown efficacy in a P2/3 trial it will remain "nice".

When there Rett trial results are in and it shows efficacy, that ODD designation becomes a "force multiplier". Till then,it's nice.

[TempePhil]

A2-73 already has ODD for Rett and Infantile spasms in US! Needs trial positive results(leaks will do!), not more ODDs, nor presentations, nor more enrollment news. Should have results in 6 months.

[Gernee20]

Skyrocket on AUS positive decision for ODD in Rett? No way. I’ve never seen a stock skyrocket on ODD news. I’ve seen jumps but they don’t hold. Yesterday’s news was nice for Long’s but nothing to make the stock appreciate. Even when they announce ODD there will be no appreciation. Get used to it, only partnership or positive readout on any 1 of the trials will make this run.